Erythropoietin Treatment in Metastatic Breast Cancer

Author： Olsson Anna-Maria Svensson Jan-Henry Sundström Judit Bergström Stefan Edekling Thomas Carlsson Göran Hansen Jörgen Svensson Birgitta Albertsson Maria

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.41, Iss.6, 2002-10, pp. : 517-524

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Xeloda^® in the Treatment of Metastatic Breast Cancer

Oncology, Vol. 57, Iss. 1, 1999-07 ,pp. : 16-20

Karger

Access to resources Recommend Favorite

Endocrine Treatment of Metastatic Breast Cancer

Breast Care, Vol. 1, Iss. 4, 2006-09 ,pp. : 248-251

Karger

Access to resources Recommend Favorite

Bevacizumab in the Treatment of Metastatic Breast Cancer

Breast Care, Vol. 2, Iss. 2, 2007-04 ,pp. : 82-88

Karger

Access to resources Recommend Favorite

Capecitabine: treatment options in metastatic breast cancer

By Kaklamani Virginia G Gradishar William J

Expert Review of Obstretrics and Gynecology, Vol. 4, Iss. 4, 2009-07 ,pp. : 367-376

Informa Healthcare

Access to resources Recommend Favorite

Hypertriglyceridemia in patients with metastatic breast cancer and treatment with capecitabine

By Geva Shahar Lazarev Irena Geffen David Barry Ariad Samuel

Journal of Chemotherapy, Vol. 25, Iss. 3, 2013-06 ,pp. : 176-180

Maney Publishing

Access to resources Recommend Favorite